CLARENDON HOUSE, HAMILTON, D0
Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
Ross Moat Appointed Chief Operating Officer at Kiniksa Pharmaceuticals
Provides Corporate Update
Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Reg. FD
Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
Presentation JUNE 2025
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Certification of Termination of Registration of a Class of Security
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload